TickerFactsScreenerDevelopers

Candel Therapeutics, Inc. (CADL) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$9.07M2021: -$22.22M2022: -$31.42M2023: -$34.24M2024: -$27.02M2025: -$38.31M-$38.31M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$38.31M-41.8%
2024-$27.02M+21.1%
2023-$34.24M-9.0%
2022-$31.42M-41.4%
2021-$22.22M-144.9%
2020-$9.07M—